Related Experiment Video
Updated: Jun 26, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Immune response of E. cuniculi infected mice to aflatoxin B1
M Levkutová1, M Levkut, V Hipíková
1University of Veterinary Medicine, Kosice, Slovak Republic.
Abstract:
The immunomodulatory effects of aflatoxin B1 (AFB1) on mice experimentally infected with Encephalitozoon cuniculi (E. cuniculi) were studied. Mice inoculated intraperitoneally with spores of E. cuniculi drank a daily solution of AFB1 (0.2 mg kg(-1) of body weight) for 27 days. Application of AFB1 to mice demonstrated a decrease of immunocompetent cells. On the other hand, the mice infected with E. cuniculi and given AFB1 showed significant increased number of both monocytes and CD8+ T cells, and tendency to a decrease in CD4+ T cells. Aflatoxin B1 revealed to merely modulate systemic immune response of E. cuniculi infected mice.
Insights
Aflatoxin B1 (AFB1) exposure modulated the immune response in mice infected with Encephalitozoon cuniculi (E. cuniculi). AFB1 altered immune cell populations, including monocytes and T cells, indicating a complex interaction.
Area of Science:
- Immunology
- Toxicology
- Parasitology
Background:
- Encephalitozoon cuniculi (E. cuniculi) is an intracellular parasite causing opportunistic infections.
- Aflatoxin B1 (AFB1) is a mycotoxin known for its toxic and immunosuppressive properties.
- The combined effects of E. cuniculi infection and AFB1 exposure on the host immune system require further investigation.
Purpose of the Study:
- To investigate the immunomodulatory effects of AFB1 on mice experimentally infected with E. cuniculi.
- To analyze the changes in specific immune cell populations following AFB1 administration in infected mice.
Main Methods:
- Mice were infected with E. cuniculi spores via intraperitoneal inoculation.
- Mice received daily oral administration of AFB1 (0.2 mg/kg body weight) for 27 days.
- Flow cytometry was used to assess changes in immunocompetent cell populations, including monocytes, CD4+ T cells, and CD8+ T cells.
Main Results:
- AFB1 administration led to a general decrease in immunocompetent cells.
- In E. cuniculi infected mice receiving AFB1, a significant increase in monocytes and CD8+ T cells was observed.
- A tendency towards a decrease in CD4+ T cells was noted in AFB1-treated infected mice.
Conclusions:
- AFB1 acts as an immunomodulator in the context of E. cuniculi infection.
- The study highlights AFB1's complex impact on the systemic immune response, altering key immune cell subsets in infected hosts.

